Abstract. The leading cause of death among cancer patients is tumor metastasis. Tumor-derived exosomes are emerging as mediators of metastasis. In the present study, we demonstrated that exosomes play a pivotal role in the metastatic progression of colorectal cancer. First, a nude mouse model of colorectal cancer liver metastasis was established and characterized. Then, we demonstrated that exosomes from a highly liver metastatic colorectal cancer cell line (HT-29) could significantly increase the metastatic tumor burden and distribution in the mouse liver of Caco-2 colorectal cancer cells, which ordinarily exhibit poor liver metastatic potential. We further investigated the mechanisms by which HT-29-derivedexosomes influence the liver metastasis of colorectal cancer and found that mice treated with HT-29-derived exosomes had a relatively higher level of CXCR4 in the metastatic microenvironment, indicating that exosomes may promote colorectal cancer metastasis by recruiting CXCR4-expressing stromal cells to develop a permissive metastatic microenvironment. Finally, the migration of Caco-2 cells was significantly increased following treatment with HT-29-derived exosomes in vitro, further supporting a role for exosomes in modulating colorectal tumor-derived liver metastasis. The data from the present study may facilitate further translational medicine research into the prevention and treatment of colorectal cancer liver metastasis.
Introduction
Colorectal cancer (CRC) is a major cause of patient morbidity and mortality worldwide. More than 1.2 million new cases of colorectal cancer occur every year globally, accounting for 10% of all cancer cases (1) . In the clinic, the liver is the most common site for human colon cancer metastasis, and patients with untreated liver metastases have a median survival of only 5-10 months. Surgical resection remains the only known effective intervention for liver metastasis. However, the 5-year survival rates of patients treated by this method are just 30-50%. Therefore, it is necessary to understand the mechanisms of liver metastasis of CRC, so that it can be prevented or significantly delayed.
Previous studies have shown that CRC metastasis is related to the communication between tumor cells and bone marrowderived hematopoietic progenitor cells via secreted factors such as chemokines and cytokines. These signals create a microenvironment that is suitable for the homing and proliferation of tumor cells (2) . Recently, it has been revealed that a type of tumor-derived small membrane vesicles (also known as exosomes) are actively involved in pre-metastatic niche formation and metastasis (3) (4) (5) . Exosomes, which are secreted by a variety of cell types of endosomal origin, are small membrane vesicles ranging from 30 to 150 nm in diameter. Exosomes participate in cell communication by transferring proteins and genetic materials (e.g., mRNAs and microRNAs) between cells (6) (7) (8) . Originally, exosomes were considered as organelles with the function of removing intracellular debris, but in 1996, exosomes were shown to be involved in immunological (9) . Since then, an increasing number of studies have focused on exosomes, and as the constituents of exosomes and their biological functions have become clearer, exosomes have attracted growing interest. During the previous decade, a number of studies have shown that exosomes are functional in modulating the growth and metastasis of melanoma, breast cancer, glioblastoma and pancreatic adenocarcinoma (5, (10) (11) (12) (13) . It has been shown that exosomes play important roles in the epithelial-tomesenchymal transition, cancer stemness, programmed cell death, apoptosis, angiogenesis and metastasis (14, 15) . Studies on melanoma have demonstrated that exosomes from highly metastatic melanomas can increase the metastatic behavior of primary tumors by permanently 'educating' bone marrow progenitors, inducing vascular leakiness at pre-metastatic sites, and reprogramming bone marrow progenitors toward a pro-vasculogenic phenotype (4). Other studies have also supported that exosomes are key regulators of the invasion and metastasis of melanomas (10, 11, 16, 17) , and similarly, that breast cancer cells secrete exosomes into the metastatic microenvironment to promote the initiation of metastasis by transferring miRNAs to target cells (5) . The mechanisms of metastasis differ between cancer types, and so the underlying detail of how exosomes regulate the metastasis of different malignancies is likely to vary. Studies employing mRNA and protein expression profiling techniques have shown that CRC cell-derived exosomes contain many microRNAs or proteins associated with oncogenes or metastasis-related genes (18) (19) (20) (21) (22) (23) (24) (25) suggesting that exosomes might be related to liver metastasis of CRC. Nevertheless, no direct evidence for exosomes promoting CRC metastasis has previously been provided, and the present study aimed to explore the potential role of exosomes in promoting CRC liver metastasis.
Metastasis is a process of several sequential, interrelated steps, and represents a highly organized, non-random and organ-selective pattern (26, 27) . A wide variety of molecules, including cytokines, chemokines and their receptors, and growth factors, have been implicated in the promotion of metastasis (28) (29) (30) (31) (32) . An accumulation of evidence suggests that tumor metastasis is associated with the SDF-1/CXCR4 axis in many types of cancers (33) (34) (35) (36) (37) , but the connection between exosomes and CXCR4 has not been evaluated. In the present study, we demonstrated the potential involvement of the SDF-1/CXCR4 signaling pathway in the process of exosomemediated metastasis of CRC cells.
Metastasis, i.e., the spread of cells from the primary neoplasm to distant organs and their relentless growth into secondary tumors, is a complex process including two major phases: firstly, translocation of a cancer cell from the primary tumor to a distant tissue, and secondly, colonization of the destination tissue. Migration is a key step for tumor cells to invade and metastasize to distant sites. In the present study, we illustrated that CRC-derived exosomes can promote the migration of cancer cells.
We found that exosomes derived from HT-29 CRC cells play important roles in promoting colorectal tumor liver metastasis. This study is the first to report that HT-29-derived exosomes directly promoted the liver metastasis of Caco-2 cells, indicating a pivotal role for exosomes in regulating the liver metastasis of CRC. The mechanisms of the HT-29-derived exosomes in promoting Caco-2 cell liver metastasis might be associated with the SDF-1/CXCR4 axis, and the effect of the exosomes in promoting tumor cell migration may influence the increased CRC liver metastasis. The data from this study may provide useful information to assist future translational medicine studies in identifying new approaches for the prevention and treatment of colorectal cancer liver metastasis. Exosome purification and characterization. Cells were cultured in media supplemented with exosome-depleted FBS. FBS was depleted of bovine exosomes by ultracentrifugation at 100,000 x g for 70 min. Supernatant fractions were collected from the cell cultures after a 24-to 48-h incubation after pelleting the cells by centrifugation at 2000 x g for 30 min. Exosomes were then harvested from the supernatants using total exosome isolation reagent (from cell culture media) (Life Technologies; cat no. 4478359) according to the manufacturer's instructions. Exosomal proteins were isolated with a total exosome RNA and protein isolation kit (Life Technologies; cat no. 4478545). The concentrations of isolated proteins were quantified by bicinchoninic acid assay (Beyotime, Beijing, China; cat. no. P0010S).
Materials and methods

Mice
Electron microscopy. Exosomes purified as described above were fixed in 2% (w/v) paraformaldehyde (PFA) in 200 mM phosphate-buffered saline (PBS) (pH 7.4). Fixed exosomes were dropped onto a Formvar/carbon-coated grid and left to dry at room temperature for 20 min. After washing in PBS, the exosomes were fixed in 1% (w/v) glutaraldehyde for 5 min, washed in water, and stained with saturated aqueous uranyl oxalate for 5 min. Samples were then embedded in a solution of 0.4% (w/v) uranyl acetate and 1.8% (w/v) methylcellulose and incubated on ice for 10 min. The excess liquid was then removed. The grid was dried at room temperature for 10 min and viewed using an electron microscope (jEM-2100; jEOL, Tokyo, japan) (38) .
Western blot analysis. Exosomal proteins (isolated as described above) were resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene difluoride (PVDF) membrane (Millipore, Billerica, MA, uSA; cat. no. IPVH00010) at 100 V for 45 min. After blocking in Tris-buffered saline containing 0.05% (v/v) Tween-20 (TBST) containing 5% (w/v) skimmed milk powder at room temperature for 2 h, the membranes were incubated with primary antibodies specific to heat-shock protein (HSP)70 (BD Biosciences, San jose, CA, uSA; cat. no. 610607; 1:2000 dilution) and cluster of differentiation (CD)63 (Abcam, Cambridge, uK; cat no. ab8219; 1:200 dilution) overnight at 4˚C. Antibodies to β-actin (Sigma-Aldrich, St. Louis, MO, uSA; cat no. A1978; 1:1000 dilution) were used as loading controls. The membranes were then rinsed three times with TBST and incubated with goat anti-mouse IgG at a dilution of 1:2,000 at room temperature for 90 min. After three final washes with TBST, the membranes were developed using an enhanced chemiluminescence kit (Beyotime; cat. no. P0018).
Flow cytometry (FACS).
For FACS analysis, exosomes were coated onto 4-mm-diameter aldehyde/sulfate latex beads (Life Technologies; cat. no. A37304), as individual exosomes are too small to be visualized by FACS. Briefly, 30 µg exosomes were incubated with 100 µl 4-mm-diameter aldehyde/sulfate latex beads for 15 min at room temperature. The mixture was then transferred to 900 µl of PBS and incubated at room temperature for a further 2 h. The coupling reaction was terminated by the addition of 100 mM glycine. Exosome-coated beads were stained with primary mouse monoclonal antibodies directed against CD63, washed twice, incubated with Alexa Fluor ® 488-labeled secondary antibody in darkness for 60 min, and analyzed by flow cytometry (guava easyCyte™ HT; Millipore).
Metastasis and liver colonization studies.
To develop a mouse model of hepatic metastasis, tumor cells were implanted into the spleens of nude mice. HT-29 or Caco-2 cells [1x10 6 cells in 100 µl Hank's balanced salt solution (HBSS)] were injected into the spleen of 6-week-old Balb/c male mice, with 10 animals per treatment group. The mice were sacrificed 8 weeks after injection of the tumor cells, and liver metastases were enumerated immediately. To analyze the role of exosomes in tumor metastasis, 6-week-old Balb/c nude male mice were injected intrasplenically with 1x10 6 Caco-2 cells. After the implantation of Caco-2 cells, 10 µg HT-29-derived exosomes were intravenously injected every three days for 28 days. We injected equal and physiological concentrations of Caco-2-derived exosomes intravenously into the control mice. Each group contained 6-8 mice. Autopsies were performed after 14 weeks and the presence of metastases was examined macroscopically. All liver samples were dissected and divided into two parts: one part was frozen for RNA extraction and quantitative reverse transcriptase-PCR (qRT-PCR) assay, while the other part was fixed in 4% (w/v) PFA for histologic analysis. The tissues used to evaluate metastasis in the liver and the metastatic microenvironment were paraffin embedded and cut into slices. The sections were stained with hematoxylin and eosin or immunohistochemically stained, and metastases were evaluated by inverted microscopy (IX71; Olympus, Tokyo, japan).
Quantitative reverse transcriptase-PCR. Total RNA was extracted from the frozen liver tissue from each mouse using TRIzol ® (Life Technologies; cat no. 10296010). The RNA samples were used to generate cDNA using Moloney murine leukemia virus reverse transcriptase (Takara; cat. no. D2639A).
The cDNA samples were used as templates for SYBR ® Green qPCR (ABI7500; Applied Biosystems, Foster City, CA, uSA). The primer pairs for the genes were designed using Beacon Designer 8 software (Premier Biosoft, Palo Alto, CA, uSA) and synthesized by Life Technology. The oligonucleotide primer sequences were as follows: 5'-GTAGAACTGTAGAG GAAGAA-3' (sense) and 5'-CGGAATGAAGAGATTAT GC-3' (antisense) for CXCR4; 5'-AACAGACAGAGTAAG GAA-3' (sense) and 5'-CTAACAATTCTACAGAGTATTC-3' (antisense) for SDF-1; 5'-GGCTGTATTCCCCTCCATCG-3' (sense) and 5'-CCAGTTGGTAACAATGCCATGT-3' (antisense) for β-actin. β-actin was used as an endogenous reference. Gene expression levels were calculated as 2 -ΔΔCt values.
Immunohistochemistry. Immunohistochemistry was performed to examine the expression of CXCR4 around the liver metastatic niche. The sections of surgical specimens were deparaffinized with xylene and rehydrated with ethanol. Migration assay. The migration assay was performed in 24-well Transwell ® plates (Corning, New York, NY, uSA; cat. no. 3422) using inserts with 8-µm pore size membranes. To investigate the role of exosomes in cell migration, Caco-2 cells were co-cultured with exosomes derived from HT-29 or Caco-2 cells before being seeded onto the top chamber. Caco-2 cells were suspended at 1x10 6 cells/ml and mixed with 10 µg/ml exosomes in Dulbecco's modified Eagle's medium (DMEM) without FBS, then added to the upper chambers, and the same medium containing 20% FBS was placed in the lower chamber. Blank controls without exosomes were set up at the same time. After 36 h, cells on the lower membrane were stained with crystal violet (Beyotime; cat no. C0121) for 15 min and counted under a light microscope in at least five different fields (original magnification, x200). Each clone was plated in triplicate in each experiment.
Results
Construction of the CRC liver metastasis animal model with HT-29 and Caco-2 cells. It has been demonstrated that HT-29
cells are highly metastatic to the liver, while Caco-2 cells do not induce liver metastasis when intrasplenically injected into nude mice (39, 40) . To confirm these prior reports, 10 6 HT-29 or Caco-2 cells were inoculated into 6-week old male nude mice by intrasplenic injection (39, 41) . In agreement with the results of previous studies, after 8 weeks, all of the 10 mice injected with HT-29 cells bore tumors in the liver (Fig. 1A) . However, of the 10 mice injected with Caco-2 cells, no mice developed tumors in the liver (Fig. 1B) . Furthermore, the results of hematoxylin and eosin (H&E) staining also showed evidence for a metastatic niche in sections from the HT-29-seeded mice livers, whereas no evidence was noted for a metastatic niche in sections from the livers of the Caco-2-seeded mice (Fig. 1C  and D) .
Characterization of the exosomes derived from HT-29 and
Caco-2 colorectal cancer cells. To investigate the role of exosomes in CRC liver metastasis, exosomes were isolated from the cell culture media of HT-29 and Caco-2 cells, and their identity was confirmed by electron microscopy, western blotting and flow cytometry. The vesicles isolated from the HT-29 cells appeared as round-shaped 60-100 nm diameter vesicles under electron microscopy ( Fig. 2A) , whereas culture media from the Caco-2 cells contained a heterogeneous population of vesicles comprising both round-shaped 40-80 nm diameter vesicles, as well as larger vesicles ~80-120 nm in diameter (Fig. 2B) , consistent with exosomes (8, 42) . We further confirmed whether these vesicles were exosomes by performing western blotting with antibodies against two commonly used exosomal markers, the tetraspanin molecule CD63 and HSP70 (8, 38, 43) . The exosomes isolated from the cell culture media of both cell types contained CD63 and HSP70 at high levels (Fig. 2C) . Results of flow cytometry also showed CD63 to be present in exosomes from HT-29 and Caco-2 cells (Fig. 2D and E) (7) .
Investigation of the effect of HT-29-derived exosomes on Caco-2 cell liver metastasis.
To examine the role of tumor-derived exosomes in CRC liver metastasis, HT-29-or Caco-2-derived exosomes were administered to mice by intravenous injection, starting 5 days after the intrasplenic injection of Caco-2 cells. Only 57% of the mice treated with exosomes derived from Caco-2 cells showed liver metastasis at 14 weeks after the tumor cells were injected, and there were only small tumor nodules on the surfaces of the livers (4/7 mice) (Fig. 3B) . However, all the mice treated with exosomes from the HT-29 cells showed evident liver metastasis and had a greater metastatic burden in the liver (8/8 mice) compared with the mice treated with exosomes derived from the poorly metastatic Caco-2 cells (Fig. 3A) . H&E staining also supported these results (Fig. 3C and D) . These findings strongly indicate that exosomes from highly metastatic CRC cells could enhance the metastatic capability of poorly metastatic CRC cells.
Putative mechanisms of HT-29-derived exosomes on
promoting Caco-2 cell liver metastasis: Investigation of the SDF-1α/CXCR4 axis. The SDF-1α/CXCR4 axis plays important roles in many types of malignancies, including lung, brain, prostate and breast cancers (35, 36) . We speculated that exosomes might regulate tumor metastasis through this signaling pathway. To investigate this hypothesis, the expression levels of SDF-1α and CXCR4 in the metastatic microenvironment of the liver tissues of the animal models were analyzed by quantitative reverse transcriptase-PCR (qRT-PCR) and immunohistochemistry. The CXCR4 mRNA level in the liver of the HT-29-implanted mice was significantly higher than that of the Caco-2-implanted mice (Fig. 4A, P<0 .05), which is consistent with the results of immunohistochemistry (Fig. 4E and F) . Treatment with HT-29-derived exosomes led to an increase in the expression level of CXCR4 in the liver of the Caco-2-implanted mice compared with those treated with the Caco-2-derived exosomes (Fig. 4C, P=0.15) . The results of immunohistochemistry also revealed that CXCR4 showed a higher protein level in the liver of the HT-29-derived exosome-treated Caco-2-implanted mice, in comparison with the Caco-2-implanted mice that were treated with the Caco-2-derived exosomes (Fig. 4G and H) . The expression of SDF-1 mRNA was also detected, but no significant differences in expression were observed between groups (Fig. 4B and D) .
Effects of HT-29-derived exosomes on the migration ability of Caco-2 cells in vitro.
Exosomes have previously been shown to mediate the migration of endothelial cells (44) . We investigated whether HT-29-derived exosomes could affect the migration of Caco-2 cells. In vitro cell migration assays were performed by treating Caco-2 cells with HT-29-or Caco-2-derived exosomes. Caco-2 cells without treatment with external exosomes served as the experimental control. The results showed that exosomes from both the HT-29 and Caco-2 cells significantly enhanced the migration of Caco-2 cells and that a greater number of Caco-2 cells that were treated with the HT-29-derived exosomes migrated than did those that were treated with the Caco-2-derived exosomes (Fig. 5, P=0.004 ). 
Discussion
Liver metastasis is one of the main pathological developments that leads to the death of CRC patients. Accumulating evidence indicates that exosomes are key mediators of tumor metastasis in melanoma and breast cancer (10) (11) (12) 45) . Exosomes may play a role in the generation of metastatic microenvironments, but the underlying molecular and cellular mechanisms have not been determined. This study elucidated for the first time the roles of exosomes derived from HT-29, a highly liver metastatic CRC cell line, in promotion of liver metastasis by the poorly liver metastatic Caco-2 cell line.
To verify the direct role of exosomes in CRC metastasis, we established liver metastatic nude mouse models of CRC cells by intrasplenic injection of HT-29 and Caco-2 cells, separately, to examine the characteristics of these two cell lines in their frequency and severity of liver metastasis. It was previously reported that HT-29 cells are highly metastatic to the liver, in contrast to Caco-2 cells, which have been reported to be poorly metastatic to the liver (41, 46) . Our results were consistent with those of previous reports and showed that the HT-29 cells had a significantly higher potential to undergo liver metastasis than did the Caco-2 cells (Fig. 1) . These initial findings laid the foundations for our further research. The findings were also consistent with previous results showing that HT-29 cells had a greater impact than Caco-2 cells on metastatic tumor growth after intrasplenic implantation into nude mice (39, 46, 47) . Subsequently, animal models were used to investigate the function of exosomes in liver metastasis. HT-29-or Caco-2-derived exosomes were extracted from cell culture media and characterized by electron microscopy, western blotting and flow cytometry (Fig. 2) and then administered to Caco-2-inoculated mice by intravenous injection to examine the effects of exosomes from highly metastatic CRC cells on the liver metastasis of the normally poorly liver metastatic Caco-2 cells. Treatment with HT-29-derived exosomes induced a pronounced enhancement of metastasis of Caco-2 cells (Fig. 3) . These results showed that exosomes play a key role in colorectal cancer liver metastasis.
A multitude of evidence from other cancers including melanoma and breast cancer has demonstrated that exosomes can mediate tumor metastasis by the horizontal transfer of molecules such as proteins and microRNAs (48) (49) (50) . The exosome-delivered miRNAs were found to mostly target metastasis-related pathways, such as proteases, adhesion molecules, chemokine ligands, and cell cycle-and angiogenesis-promoting genes. Studies on lung cancer and melanoma have revealed that exosomes are involved in regulating angiogenesis and epithelial-mesenchymal transition (17, 51) . However, the role of exosomes in cancer metastasis may vary among cancer types, given that the established metastatic mechanisms of different cancers are also variable. Thus, the mechanisms by which exosomes participate in the regulation of CRC liver metastasis were then elucidated.
SDF-1 and its receptor CXCR4 have prominent roles in many types of malignancies, including lung, brain, prostate, and breast cancer as well as colorectal cancer (35, 36, 52) and regulate the motility of cells, including tumor cells and MSCs (32-34,37,53,54) . Therefore, we suspected that exosomes might increase SDF-1 expression in the metastatic microenvironment and thereby attract cancer cells and other stromal cells. However, no clear differences were detected in the SDF-1 expression level among the different animal models (HT-29-or Caco-2 cell-implanted mice and HT-29-or Caco-2-derived exosome-treated Caco-2-implanted mice) (Fig. 4B and D) . On the other hand, measurement of the expression levels of CXCR4 in the livers of the HT-29 and Caco-2 xenograft models showed that the livers of the HT-29 xenograft model had significantly higher CXCR4 levels than those of the Caco-2 xenograft mouse model (Fig. 4A) . Meanwhile, HT-29-derived exosomes induced higher CXCR4 expression levels than Caco-2-derived exosomes ( Fig. 4C and E-H) . The results indicated that HT-29-derived exosomes might affect CRC metastasis by increasing CXCR4 expression by many types of stromal cells and promoting the recruitment of these CXCR4-expressing stromal cells to develop a suitable metastatic microenvironment. However, the underlying mechanisms need further investigation.
Cancer metastasis is a complex process involving multiple steps, including invasion, angiogenesis, trafficking of cancer cells through blood vessels, extravasation, organ-specific homing and growth. Tumor cell migration is one of the most important steps of tumor metastasis. Whether HT-29-derived exosomes can affect the migration of Caco-2 cells was examined by cell migration assay in vitro. Our results showed that exosomes from both HT-29 and Caco-2 cells promoted the migration of Caco-2 cells, and HT-29-derived exosomes had a greater impact on Caco-2 cell migration than Caco-2-derived exosomes did (Fig. 5) . Thus, exosomes might promote metastasis by affecting the migration of CRC cells.
In the present study, we demonstrated a pivotal role for exosomes in the liver metastasis of colorectal cancer, which may function by affecting cellular migration. We also showed that the effects of exosomes might be related to the creation of a CXCR4-enriched microenvironment, which is comprised of stromal cells including immune cells, endothelial cells, fibroblasts, bone marrow-derived cells and stem cells. Our research leads to the further understanding of how exosomes affect the liver metastasis of CRC and provide perspective regarding the therapeutic window for therapy of colorectal cancer. However, whether exosomes of CRC function similarly to those of melanoma, by promoting the 'education' and mobilization of bone-marrow derived cells or other stromal cells, and what components of exosomes are involved in the CXCR4 expression warrant further study.
